2024年11月4日,医疗销售供应商欧麦斯-麦能医疗(OMI)盘中股价大跌11.60%,报收11.80美元。这一大跌或与公司近期季报业绩低于市场预期密切相关。
公司上季度实现营业收入26.71亿美元,同比增长5%。但由于成本上升,净利润为亏损31.91百万美元,每股实现亏损0.42美元,低于分析师平均预期0.41美元的微利。
数据显示,在7家给予该股评级的券商中,仅有2家给予买入评级,3家持有评级,2家卖出评级。受季报不佳影响,部分机构已下调盈利预测及评级,增加了投资者对公司长期表现和盈利能力的担忧情绪,引发持股机构抛售。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.